Home
SCIO Path to Approval
Early Clinical Research
Strategy and TPP
Translational Medicine and Epigenetics
Biologics, Cell and Gene Therapy
Real World Evidence
Repurposing
Orphan Drug Solutions
Biomarkers and Surrogate Endpoints
Regulatory Affairs FDA and EMA
Medical Affairs and Clinical Research
Due Diligence
Trial Management & Trial Rescue
People
Senior Advisors
Candida Fratazzi
Claudio Carini
Federico Goodsaid
Our Team
Our Clients
Our Collaborators
Testimonials
Resources
BBCR Voice
Case Studies
Published Studies
Conferences & Presentations
Job Opportunities
Contact Info
Select Page
`
Tagged: SCIO
Drug development success hinges on simplifying Clinical Research
May 16th, 2019 | SCIO
Strategic Consulting: The convergence revolution to innovate clinical trial process
May 10th, 2019 | SCIO
Strategic Consulting – SCIO Process -A New Way for Drug Development
April 30th, 2019 | SCIO
Strategic consulting reduces cost and risk of clinical trials
April 2nd, 2019 | SCIO
SCIO Helps Early Stage Biotech Company Evaluation
January 24th, 2019 | SCIO
Welcome to BBCR’s New Website!
December 7th, 2018 | SCIO
Newer posts »
Follow Us
Search for:
Categories
Biomarkers & Surrogate Endpoints
Company News
Drug Development
Due Diligence
Early Clinical Development
Industry News
Medical Affairs and Clinical Research
Miscellaneous
Orphan Diseases
Pre-IND
Precision Medicine
Rare Disease
Real World Evidence
Regulatory
Regulatory Affairs
Strategy and TPP
Translation Medicine and Epigenetics
Trial Management
Trial Rescue
Recent Posts
BBCR meets clients’ needs in the fast paced and ever-changing regulatory environment. As specialists in Orphan and Personalized Medicine, BBCR helps clients identify areas of need or economic interest and helps them to find homes for treatments for rare diseases and precision medicine.
BBCR is highly experienced in developing innovative approaches to de-risk your product development during the early clinical development stage, including designing Proof of Concept (PoC) Trials and Proof of Mechanism (PoM) studies. Learn more at bbcrconsulting.com #PoC #PoM #proofofconcept #proofofmechanism #earlyclinicaldevelopment #strategy
BBCR partners with small and medium sized drug and device biotechnology firms. Our clients are clinical researchers and innovators looking for an efficient path to approval, and come to us from across the globe. Learn more about our consulting services at bbcrconsulting.com.
From Preclinical through Phase I and POC studies, BBCR provides early clinical research services to enable informed, timely decision-making for our clients. We offer clinical, regulatory, translational, and biomarker consulting services that support our clients’ needs. Our process is designed to maximize time and cost efficiencies while mitigating risk.
With Biomarkers a routine part of drug development, BBCR assists companies with the identification and adoption of biomarkers, especially valuable in rare disease and precision medicine product development.
Pin It on Pinterest